据澳新食品标准局（FSANZ）消息，2019年7月22日，澳新食品标准局发布85-19号通告，其中1155号申请，申请批准在婴儿配方食品与其他产品中使用 2'-O-岩藻糖基乳糖（2'-FL）与乳酸-N-新四糖（LNnT）。

 

　　部分原文报道如下：

 

　　Pursuant to section 31 of the Food Standards Australia New Zealand Act 1991 （FSANZ Act）， FSANZ now calls for submissions to assist FSANZ's consideration of the draft food regulatory measure it has prepared arising from an application made by Glycom A/S to permit the voluntary addition of 2′-O-fucosyllactose （2′-FL） alone or in combination with Lacto-N-neotetraose （LNnT）， produced by microbial fermentation, in infant formula products and formulated supplementary foods for young children. The purpose of the application is to permit the voluntary use of 2'-O-fucosyllactose （2'-FL） alone or in combination with Lacto-N-neotetraose （LNnT）， produced by microbial fermentation using genetically modified Escherichia coli （E.coli） strains, in infant formula products and formulated supplementary foods for young children （FSFYC）。